https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
Renal fibrosis is a common pathological outcome of chronic kidney diseases (CKD) that is considered as a global public health issue with high morbidity and mortality. The dry corolla of (L.) Medik. (AMC) has been used for chronic nephritis in clinic and showed a superior effect in alleviating proteinuria in CKD patients to losartan. However, the effective components and underlying mechanism of AMC in the treatment of renal fibrosis have not been systematically clarified. Based on drug-likeness evaluation, oral bioavailability
Curtir
Comentario
Compartilhar
